studies on retatrutide Phase III study demonstrates 30% weight loss Retatrutide | Metabolic Research Peptides

However, this effect has not been reported in humans

Disclaimer: Prescription medication eligibility is subject to meeting specific criteria determined by licensed healthcare professionals

This is why tirzepatide outperforms semaglutide in most clinical studies

Weeks 3-4: First Noticeable Weight Changes By the end of the first month, many individuals begin seeing measurable progress

Weekly dosage schedule Starting dose: 0.25 mg weekly for first 4 weeks Titration phase: 0.5 mg weekly for 4 weeks and then, if tolerated, 1 mg weekly for 4 weeks Maintenance dose for long-term weight management: 1.7 mg once weekly for 4 weeks and then, if tolerated, 2.4 mg once weekly (maximum dose) Dosing considerations If you do not tolerate dose escalation, consult with your healthcare provider and consider delaying the dose escalation for at least 4 weeks